<DOC>
	<DOCNO>NCT01480869</DOCNO>
	<brief_summary>The purpose study compare normalization vitamin D serum level 6 month vitamin D supplementation adjust baseline vitamin D serum level vs.conventional vitamin D supplementation .</brief_summary>
	<brief_title>Study Vitamin D Supplementation Tailored Vitamin D Deficiency Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>Breast adenocarcinoma treat neoadjuvant adjuvant chemotherapy within 12 month prior study enrollment WHO performance status 01 Age ≥18 year old Affiliation social security regime beneficiary equivalent social protection Written inform consent provide study specific procedure Complementary inclusion criterion randomization Proved vitamin D deficiency define serum vitamin D level lower 30 ng/ml ( 75 nmol/L ) . Metastatic disease History presence malignancy ( except curatively treat nonmelanoma skin cancer situ cervix carcinoma ) ………… . traités dans les 5 an précédents . Contraindication calcium cholecalciferol Known severe hypersensitivity vitamin D calcium supplementation one excipients . Disease and/or medical condition accompany hypercalcaemia and/or hypercalciuria Calcium lithiasis tissue calcification Hypervitaminosis D Presence significant comorbidities : ) Uncontrolled endocrine disease ii ) Known disorder calcium phophorus laboratory test iii ) Proved osteopenia osteoporosis require vitamin D calcium supplement Concomitant treatment experimental product another vitamin D calcium treatment Pregnancy , breastfeed reproductive potential use effective contraceptive method Legal inability restrict legal ability . Medical psychological condition allow proper study completion inform consent signature</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Vitamin D supplementation</keyword>
	<keyword>neoadjuvant</keyword>
	<keyword>adjuvant setting</keyword>
</DOC>